ArticleCancers2021

Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers.

William Jacot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.